Freestone Grove Partners LP Natera, Inc. Transaction History
Freestone Grove Partners LP
- $8.16 Trillion
- Q4 2024
A detailed history of Freestone Grove Partners LP transactions in Natera, Inc. stock. As of the latest transaction made, Freestone Grove Partners LP holds 4,183 shares of NTRA stock, worth $722,027. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,183Holding current value
$722,027% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NTRA
# of Institutions
634Shares Held
123MCall Options Held
821KPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA12.3MShares$2.13 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.17 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.74MShares$1.16 Billion0.12% of portfolio
-
Jpmorgan Chase & CO New York, NY6.7MShares$1.16 Billion0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.43MShares$765 Million3.74% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $16.7B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...